Newsletter
Alirocumab for Coronary Atherosclerosis, Flying Stroke Intervention Team, USPSTF Recommendation on COPD Screening, and more

JAMA Editor’s Summary

Alirocumab for Coronary Atherosclerosis, Flying Stroke Intervention Team, USPSTF Recommendation on COPD Screening, and more

Editor's Summary by Kristin Walter, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the issue.
May 10, 2022

Alirocumab for Coronary Atherosclerosis, Flying Stroke Intervention Team, USPSTF Recommendation on COPD Screening, and more

Editor’s Summary by Kristin Walter, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the May 10, 2022 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
What Will Variant Sigma Look Like? with Michael T. Osterholm, Ph.D., Regents Professor, Division of Environmental Health Science; Director, Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota